Switch From Enfuvirtide to Raltegravir in Patients With Undetectable Viral Load: Efficacy and Safety at 24 Weeks in a Montreal Cohort
暂无分享,去创建一个
Réjean Thomas | C. Torti | I. Izzo | G. Carosi | P. Airó | R. Lalonde | M. Scarsi | N. Machouf | Suzanne Marcotte | G. Carella | A. Malagoli | B. Lessard | A. Talbot | R. Therrien | S. Dufresne